BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14656003)

  • 1. Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors.
    Rotondo F; Vidal S; Bell D; Horvath E; Kovacs K; Scheithauer BW; Lloyd RV
    Acta Histochem; 2003; 105(4):303-7. PubMed ID: 14656003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
    de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
    Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.
    Rotondo F; Kovacs K; Horvath E; Bell CD; Lloyd RV; Scheithauer BW
    Acta Neuropathol; 2006 Mar; 111(3):272-7. PubMed ID: 16538520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.
    Verchere CB; D'Alessio DA; Wang S; Andrikopoulos S; Kahn SE
    Horm Metab Res; 1997 Jun; 29(6):311-6. PubMed ID: 9230354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid in polypeptide hormone-producing tumors.
    Westermark P; Grimelius L; Polak JM; Larsson LI; Van Noorden S; Wilander E; Pearse AG
    Lab Invest; 1977 Aug; 37(2):212-5. PubMed ID: 881783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amylin in human pancreatic islets.
    Tomita T
    Pathology; 2003 Feb; 35(1):34-6. PubMed ID: 12701681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
    Milton NG; Harris JR
    Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multihormone-producing islet cell tumor of the pancreas associated with somatostatin-immunoreactive amyloid: immunohistochemical and immunoelectron microscopic studies.
    Takahashi M; Hoshii Y; Kawano H; Setoguchi M; Gondo T; Yamashita Y; Nakayasu K; Kamei T; Ishihara T
    Am J Surg Pathol; 1998 Mar; 22(3):360-7. PubMed ID: 9500779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
    Yagui K; Kanatsuka A; Makino H
    Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
    Sanno N; Teramoto A; Matsuno A; Osamura RY
    Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
    Tomita T
    Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
    Lorenzo A; Razzaboni B; Weir GC; Yankner BA
    Nature; 1994 Apr; 368(6473):756-60. PubMed ID: 8152488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of non-classical islet hormone-like peptides during the embryonic development of the pancreas.
    Mulder H; Myrsén-Axcrona U; Gebre-Medhin S; Ekblad E; Sundler F
    Microsc Res Tech; 1998 Nov; 43(4):313-21. PubMed ID: 9849972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effects of islet amyloid polypeptide (amylin) on exocrine pancreas and gastrin release in conscious rats.
    Funakoshi A; Miyasaka K; Kitani K; Nakamura J; Funakoshi S; Fukuda H; Fujii N
    Regul Pept; 1992 Mar; 38(2):135-43. PubMed ID: 1574608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
    Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
    Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin releasing peptide in human neuroendocrine tumours.
    Bostwick DG; Bensch KG
    J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amylin on prolactin release.
    Chmielowska M; Wolińska-Witort E; Martyńska L; Baranowska B
    Neuro Endocrinol Lett; 2005 Dec; 26(6):680-4. PubMed ID: 16380707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.